TURKISH JOURNAL OF PATHOLOGY, cilt.36, sa.2, ss.154-158, 2020 (ESCI)
Objective: The aim of this study to evaluate histopathological improvement and virological, serological and biochemical response rates in patients with chronic hepatitis B (CHB) who were treated with tenofovir disoproxil fumarate (TDF).